Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Prevention of Peritonitis in PD Patients
NCT05860270Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2023
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in peritonitis (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Hazard Ratio of Subsequent peritonitis at 24 months. Started Jun 2023; status: recruiting.
02
Drugs
vitamin d
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT05860270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05860270.